Tricia Haugeto
Keine laufenden Positionen mehr
Karriereverlauf von Tricia Haugeto
Ehemalige bekannte Positionen von Tricia Haugeto
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Investor Relations Kontakt | - | 01.01.2019 |
| Public Communications Contact | 11.10.2010 | 01.01.2019 |
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Börse
- Insiders
- Tricia Haugeto
- Erfahrung
